SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001562762-20-000164
Filing Date
2020-05-05
Accepted
2020-05-05 14:22:51
Documents
54
Period of Report
2020-03-28

Document Format Files

Seq Description Document Type Size
1 10-Q usna-20200328x10q.htm   iXBRL 10-Q 1948726
2 EX-31.1 usna-20200328xex31_1.htm EX-31.1 14979
3 EX-31.2 usna-20200328xex31_2.htm EX-31.2 15247
4 EX-32.1 usna-20200328xex32_1.htm EX-32.1 6422
5 EX-32.2 usna-20200328xex32_2.htm EX-32.2 6338
  Complete submission text file 0001562762-20-000164.txt   5422354

Data Files

Seq Description Document Type Size
6 EX-101.SCH usna-20200328.xsd EX-101.SCH 25071
7 EX-101.CAL usna-20200328_cal.xml EX-101.CAL 43312
8 EX-101.DEF usna-20200328_def.xml EX-101.DEF 46823
9 EX-101.LAB usna-20200328_lab.xml EX-101.LAB 205708
10 EX-101.PRE usna-20200328_pre.xml EX-101.PRE 172777
29 EXTRACTED XBRL INSTANCE DOCUMENT usna-20200328x10q_htm.xml XML 987947
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

IRS No.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: 10-Q | Act: 34 | File No.: 001-35024 | Film No.: 20848302
SIC: 2833 Medicinal Chemicals & Botanical Products